Direct comparison of two extended half-life PEGylated recombinant FVIII products

Solms A., Shah A., Berntorp E., Tiede A., Iorio A., Linardi C., Ahsman M., Mancuso M. E., Zhivkov T., Lissitchkov T. Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A. Ann. Hematol. 99(11): 2689–2698, 2020 [Link to publication].

Read More